Vaccines alone may not be enough to end COVID-19 pandemic
In a new study, researchers found that even as vaccines are becoming more readily available in the U.S., protecting against the asymptomatic spread of...
This hormone therapy may improve COVID-19 outcomes in men
COVID-19 disproportionately affects men compared with women.
This raises the possibility that a hormone-like progesterone may improve clinical outcomes for certain hospitalized men with the...
These people more vulnerable to COVID-19 reinfection
In a new study, researchers found that reinfection with COVID-19 in people who've already had the illness is very rare, and most people are...
How to get better sleep amid the pandemic – and why you should
A good night's sleep. It's one of those things people don't appreciate until it's gone.
But like much taken for granted prior to the COVID-19...
Certain mouthwashes might stop COVID-19 transmission
In a new study, researchers found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in...
This common drug can decrease ventilation, ICU admission and death in COVID-19
In a new study, researchers found low-dose aspirin may reduce the need for mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized COVID-19 patients.
The...
Blood clots: 5 reasons they may happen
There’s been a lot of concern in recent days about blood clots, particularly after reports from Germany of people developing cerebral vein thrombosis –...
This stuff in body linked to death in severe COVID-19
In a recent study published in the American Journal of Hematology, scientists found people with severe COVID-19 who have high levels of the blood-clotting protein...
12 mental health tips as life gets ‘back to normal’
News stories. Social media “memories.” Significant dates of things that happened a year ago – or never happened because of COVID-19.
In the coming weeks...
This drug holds promise as at-home treatment for COVID-19
In a new study, researchers found that the leprosy drug clofazimine, which is FDA approved, can fight against SARS-CoV-2 and prevents the exaggerated inflammatory...